Chord Energy Corporation (the "Company," "we," "us," or "our"), announced today that, subject to market conditions, it intends to offer $750 million in aggregate principal amount of senior unsecured ...

TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the fourth quarter and full year ended December 31, 2024, along with recent company ...